Equity Overview
Price & Market Data
Price: $0.83
Daily Change: -$0.0331 / 3.99%
Range: $0.83 - $0.83
Market Cap: $8,975,218
Volume: 100
Performance Metrics
1 Week: 9.23%
1 Month: 44.24%
3 Months: 74.34%
6 Months: 23.29%
1 Year: 9.24%
YTD: 43.09%
Company Details
Employees: 23
Sector: Health technology
Industry: Pharmaceuticals: major
Country: Canada
Details
Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing MC-1 for the treatment of PNPO deficiency; and TARDOXAL for neurological indications, such as Tardive Dyskinesia. It offers products through retail and mail order pharmacies. The company was founded in 1997 and is headquartered in Winnipeg, Canada.